Vardaan Biotech files DRHP with SEBI for IPO of 3.50 crore shares

Vardaan Biotech Ltd. has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on September 18, 2026, as the agricultural seed company advances its initial public offering (IPO) plans.

The proposed IPO will comprise a fresh issue of up to 3.50 crore equity shares. The company’s shares are proposed to be listed on both the National Stock Exchange (NSE) and the BSE.

Vardaan Biotech IPO details

Particulars	Details
Company	Vardaan Biotech Ltd.
DRHP filing date	September 18, 2026
IPO type	Book built issue
Issue type	Fresh issue only
Fresh issue size	Up to 3.50 crore shares
Face value	₹2 per share
Proposed listing	NSE and BSE
Lead manager	Interactive Financial Services Ltd.

The IPO will follow a defined allocation structure for different investor categories. Not more than 50% of the net issue will be reserved for Qualified Institutional Buyers (QIBs), while Non-Institutional Investors (NIIs) will receive at least 15%. Retail Individual Bidders will be allocated at least 35% of the net issue.

About Vardaan Biotech

Established in 2007, Vardaan Biotech Limited is an integrated seed company involved in the development, breeding, production, processing, conditioning and marketing of agricultural seeds.

The company produces different types of seeds, including hybrid seeds, parental lines, breeder seeds and foundation seeds across various crop categories.

Its operations cover multiple stages of the agricultural seed value chain, from seed development and breeding to processing and marketing. The company’s proposed IPO marks a step forward in its plans to access the public capital markets.

Further details, including the IPO price band, opening date, issue proceeds and financial performance, will be available through subsequent offer documents and regulatory disclosures.